Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Immunology
IF: 1.352 5-Year IF: 3.347 SJR: 1.022 SNIP: 0.55 CiteScore™: 2.19

ISSN Print: 1040-8401
ISSN Online: 2162-6472

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v28.i2.40
pages 159-183

Immune Responses Against Persistent Viral Infections: Possible Avenues for Immunotherapeutic Interventions

Shinichiro Fuse
Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03756
Michael J. Molloy
Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03756
Edward J. Usherwood
Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03756

ABSTRACT

Persistent viral infections present a significant threat to society, and treatment options for infected individuals are in urgent demand. During viral persistence, the balance between the virus and the host immune response is crucial. The immune system keeps the virus in check, and the virus counters by evading the immune response to avoid clearance, ultimately tipping the balance in favor of the virus and causing disease in many cases. Thus, efforts to tip the balance in favor of the host through immunotherapy holds promise for establishing control of viral replication. However, in most persistent viral infections, the continuous presence of the viral antigen renders virus-specific T cells to become dysfunctional. These differences can range from severe functional impairments in high-load persistent infections, to more subtle changes in infections with a lower virus burden. Recent work has shed light on immunoregulatory molecules or cytokines that affect viral persistence and/or T-cell function, and interventions that modulate these factors have led to effective viral control in experimental models. Exploitation of these experimental therapies may lead to treatments that would be of great clinical benefit to patients suffering from persistent virus infections, such as HIV, HBV, or HCV, or the herpesviruses CMV and EBV.


Articles with similar content:

Roles of Complement C1q in Pneumococcus−Host Interactions
Critical Reviews™ in Immunology, Vol.35, 2015, issue 3
Anna M. Blom, Vaibhav Agarwal
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment
Critical Reviews™ in Immunology, Vol.36, 2016, issue 5
Marilina Tampoia, Franco Dammacco, Gianfranco Lauletta, Fabio Pavone, Sabino Russi, Andrea Marzullo, Domenico Sansonno
NK Cells and Their Ability to Modulate T Cells during Virus Infections
Critical Reviews™ in Immunology, Vol.34, 2014, issue 5
Kevin D. Cook, Stephen N. Waggoner, Jason K. Whitmire
Immunological Mechanisms Involved In Experimental Peptide Immunotherapy of T-Cell-Mediated Diseases
Critical Reviews™ in Immunology, Vol.20, 2000, issue 6
Marca H. M. Wauben
The Pathogenesis of Murine Coronavirus Infection of the Central Nervous System
Critical Reviews™ in Immunology, Vol.30, 2010, issue 2
Thomas E. Lane, Martin P. Hosking